Tuberculosis Detection & Resistance

About Co-Diagnostics

Co-Diagnostics is a molecular diagnostics company focused on developing, manufacturing, and marketing tests based on its patented CoPrimer™ technology platform, which aims to improve PCR specificity and sensitivity. The company has commercialized tests for diseases including tuberculosis, hepatitis, HPV, malaria, and SARS-CoV-2, and operates a dual revenue model through direct product sales and IP licensing via its joint venture in India. Its strategy centers on expanding its infectious disease portfolio, growing its global distribution network, and leveraging its platform's flexibility for partnerships and new assay development.

Therapeutic Areas